SUBSCRIBE
SUBSCRIBE
News   Drug Development

U.S. FDA Says Takeda Pharmaceutical Co. Ltd. Sleep Drug Promotion Misleads

March 22, 2010 | 
1 min read

Reuters -- Japan's Takeda Pharmaceutical Co (4502.T) used a misleading promotion for its insomnia drug Rozerem, U.S. regulators said in a letter released on Friday.

Clinical research Postmarket research Regulatory
Takeda Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Chicago, Illinois, USA on Lake Michigan at dawn.
Cancer
AACR 2025 Tracker: GSK, Boehringer Ingelheim and Merck Kick Off Meeting With New Data
April 28, 2025
 · 
3 min read
 · 
BioSpace Editorial Staff
Creative design. Business people, managers, employees discussing strategy for achieving goal and success. Working on growth. Concept of teamwork,analytics, business, career development, promotion
Cancer
Perioperative Keytruda Cuts Risk of Negative Events by Over 25% in Head and Neck Cancer
April 28, 2025
 · 
1 min read
 · 
Tristan Manalac
Female hand showing thumbs up gesture on blue background, art collage. Positive hand sign. Fashion collage in the style of Thumbs up magazine. Contemporary art. Modern design.
Cancer
Summit, Akeso’s Keytruda Challenger Wins Chinese OK as US Approval Questions Linger
April 28, 2025
 · 
3 min read
 · 
Tristan Manalac
Stagflation, economic slow down or recession while inflation high up, GDP growth decrease causing by unemployment concept, fearful businessman riding fall down economic graph with inflation high up.
Immunology and inflammation
Vyne Crashes After Safety Signal in Dogs Puts Hold on Clinical Trial of Plaque Psoriasis
April 25, 2025
 · 
2 min read
 · 
Tristan Manalac